Ron HN van Schaik

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2D6</i> and Tamoxifen Therapy

Matthew P. Goetz, Katrin Sangkuhl, Henk‐Jan Guchelaar et al. · Clinical Pharmacology & Therapeutics · 2018 · 324 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

CYP3A5 Variant Allele Frequencies in Dutch Caucasians

Ron HN van Schaik, Ilse P. van der Heiden, John N. van den Anker et al. · Clinical Chemistry · 2002 · 303 citations · Full text

Medicine, Genetics, Pharmacotherapy +15

The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients

Marzia Del Re, Elisa Biasco, Stefania Crucitta et al. · European Urology · 2016 · 284 citations

Medicine, Molecular Biology, Oncology +17

A New Functional CYP3A4 Intron 6 Polymorphism Significantly Affects Tacrolimus Pharmacokinetics in Kidney Transplant Recipients

Laure Elens, Rachida Bouamar, Dennis A. Hesselink et al. · Clinical Chemistry · 2011 · 240 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Interpatient variability in the pharmacokinetics of the HIV non‐nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and <i>CYP2B6</i> polymorphism

David M. Burger, Ilse van der Heiden, Charles la Porte et al. · British Journal of Clinical Pharmacology · 2005 · 211 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15